Professor
Medical University Graz
Professor
Medical University Graz
Graz, Austria
Session Moderator
SESSION 20: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT – EVALUATING ARTERIAL ANATOMY AND TREATMENT OUTCOMES WITH CLTI
Presenter
SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
Presenter
SESSION 29: LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
Presenter
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
Presenter
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
Presenter
SESSION 31: ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND RIVAROXABAN
Presenter
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
Presenter
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
SESSION 20: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT – EVALUATING ARTERIAL ANATOMY AND TREATMENT OUTCOMES WITH CLTI
Presenter
SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
Is The Open Surgery First Or Endovascular First Approach Controversy Still Alive For CLTI: What Percentage Of An Interventionalist's Patients Should Be Treated First By Open Surgery
7:10 AM - 7:15 AM
Presenter
SESSION 29: LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
How And Why To Measure Foot Perfusion During And After Endo Treatments: Hyperspectral Imaging, O2 Sensors, Etc.: When Is The Angiosome Concept Helpful; When Not
4:16 PM - 4:21 PM
Presenter
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
How Should We Move Forward With Limus Coated Devices After FDA Has Cleared Paclitaxel Coated Devices: Are There Promising Results Currently With Limus Coated DCBs
10:18 AM - 10:23 AM
Presenter
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBS) AND DRUG ELUTING STENTS (DESS): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTS) AND BTK LESION TREATMENTS WITH DCBS AND DESS
Below-The-Ankle Endo Interventions In 2024: Techniques, Devices And Should Balloons Be Drug Coated Or Not
11:48 AM - 11:53 AM
Presenter
SESSION 31: ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND RIVAROXABAN
New Findings From The VOYAGER PAD And COMPASS RCTs With Low Dose Rivaroxaban (Xarelto [Janssen/J&J]) And Aspirin: How Do These Drugs Lower Major Adverse Limb And Cardiac Event Rates After Lower Extremity Revascularization (Endo And Open)
6:52 AM - 6:57 AM
Presenter
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
A New More Complex Device For Treating Calcified Arterial Lesions With Lithotripsy (From BOLT Medical): How Does It Work And Advantages
2:12 PM - 2:17 PM
Presenter
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
An Update On The Soundbite Technology For Traversing And Treating Calcified Arterial Lesions: How Does It Work, Advantages, And Clinical Experience
2:30 PM - 2:35 PM